Riskpilot← Back to searchSign inGet full accessGyros Protein Technologies AB
ABActiveOrg 5566725429Kungsängstull 4Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 200463 employees
Revenue 2025
SEK 293,1M
+23% vs 2024
EBITDA margin
-0.2%
-108% vs 2024
Equity ratio
51.9%
Financial strength
Net profit 2025
SEK -1,7M
-118% vs 2024
| Revenue | SEK 293,1M | +23% |
| EBITDA | SEK -605K | -108% |
| Net profit | SEK -1,7M | -118% |
| Total assets | SEK 191,7M | -19% |
| Equity | SEK 99,4M | -40% |
| Employees | 63 | — |
Legal name
Gyros Protein Technologies AB
Org number
5566725429
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
16 december 2004
Share capital
SEK 3 967 000
Employees
63 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av von Heijne, Eva Birgitta i förening med en av Sakys, John Vydunas Wallsten, Anders Olof Firman tecknas av Wallsten, Anders Olof i förening med en av Sakys, John Vydunas von Heijne, Eva Birgitta Firman tecknas ensam av Owens, Gary Michael Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att direkt eller indirekt utveckla, tillverka och försälja utrustning och tjänster för användning inom forskning, utveckling och tillverkning inom bioteknologi, farmakologisk och diagnostisk verksamhet, miljövård, livsmedel, jordbruk och annan därmed förenlig verksamhet.
Address
Kungsängstull 4
Phone
+4618566300
Email
information@gyros.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 176 417 | 246 422 | 250 820 | 238 351 | 293 071 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 10 739 | 64 380 | 28 323 | 7 380 | −605 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 10 739 | 64 380 | 28 323 | 7 380 | −605 |
| Net financials | −1 888 | −3 | 1 150 | 2 928 | 4 203 |
| Profit before tax | 9 873 | 64 377 | 29 473 | 10 308 | 3 598 |
| Tax | −0 | −0 | 22 500 | −779 | −5 326 |
| Net profit | 9 873 | 64 377 | 51 973 | 9 529 | −1 728 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 234 606 | 235 932 | 292 382 | 237 016 | 191 738 |
| Equity | 135 404 | 104 984 | 212 160 | 166 247 | 99 426 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 99 202 | 130 687 | 80 222 | 70 508 | 92 312 |
| Total debt | 99 202 | 130 687 | 80 222 | 70 508 | 92 312 |
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
20212025
Equity ratio
51.9%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
-1.7%
This company
18.4%
Market median
-109% vs market
20212025
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
20212025
Asset turnover
1.53×
This company
1.12×
Market median
+37% vs market
20212025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ÅS Chief Auditor | Chief Auditor | 2021 |
AO External Signatory | External Signatory | 2022 |
EB Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (3) | ||
MJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 – 2026 |
KA Chief Auditor | Chief Auditor | 2020 – 2021 |
ML Chief Auditor | Chief Auditor | 2023 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MESA LABORATORIES, INCMLI Sweden Holdco ABGyros Protein Technologies Holding AB
Gyros Protein Technologies AB (this company)GYROS JAPAN KKGyros Japan KkGyros Fr SarlGYROS FR SARLGYROS DE GMBHGyros De GmbhGYROS UK LTDGyros Uk LtdBoard members of Gyros Protein Technologies AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Johannes Vossenaar | Deputy Chief Executive Officer | 0 companies |
| Åsa Sofia Thelin | Chief Auditor | 0 companies |
| Anders Olof Wallsten | External Signatory | 0 companies |
| Karl Anders Fornstedt | Chief Auditor | 0 companies |
| Malin Lanneborn | Chief Auditor | 0 companies |
| Eva Birgitta von Heijne | Chief Executive Officer | 0 companies |
| Gary Michael Owens | Board of Directors | 0 companies |
| Maisa Johanna Alakulppi-Cazorte | Board of Directors | 0 companies |
| Cetin Eskinyurt | Deputy Board Member | 0 companies |
| John Vydunas Sakys | Chairman | 0 companies |